RESEARCH & PROJECTS
SCIENCE & PROJECTS
AFNET plans and conducts investigator-initiated studies, registries and research projects. Below you will find an overview of the current studies with AFNET as sponsor:
2024 to approx. 2030
EASThigh – AFNET 11
Early atrial fibrillation Ablation for STroke prevention in patients with high comorbidity burden.
2026
FanBeats
Awareness campaign on heart health in partnership with football fans.
2025 – 2026
EOLS – End of life survey
A systematic study of the psychological situation and self-assessment regarding the end of life among ICD recipients.
2021 to approx. 2026
MAESTRIA – AFNET 10
Machine Learning Artificial Intelligence Early Detection STroke Atrial Fibrillation.
2017 – 2023
AXADIA – AFNET 8
Safety Study Assessing Oral Anticoagulation with Apixaban versus Vitamin-K Antagonists in Patients with Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment.
2016 – 2023
NOAH- AFNET 6
Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High-rate episodes.
2021 – 2022
Smart in OAC-AFNET 9
Remote, investigator-initiated Smartphone and wearable detected atrial arrhythmia in Older Adults Case finding study.
2011 – 2021
EAST – AFNET 4
Early treatment of atrial fibrillation for stroke prevention trial (EAST).
2015 – 2018
AXAFA – AFNET 5
Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy (AXAFA).
2005 – 2012
Flec-SL – AFNET 3
Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion.
2006 – 2011
Gap-AF – AFNET 1
Catheter ablation of arial fibrillation by linear pulmonary vein isolation.
2005 – 2009
ANTIPAF – AFNET 2
Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation Trial (ANTIPAF Trial)/p>
You can help!
Doctors with expertise
Contact us directly to actively participate in our ongoing studies, be it through patient recruitment, as investigator or consultant
2004 – 2010
Studie AFNET 99 Studie
Frühe Behandlung von Vorhofflimmern zur Verhinderung von Schlaganfällen
2030
2029
2028
2027
2026
2004 – 2010
Studie AFNET 99 Studie
Frühe Behandlung von Vorhofflimmern zur Verhinderung von Schlaganfällen